本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Soleno Therapeutics

73.30
-1.7500-2.33%
盘后73.27-0.0300-0.04%17:36 EDT
成交量:51.43万
成交额:3,781.52万
市值:36.94亿
市盈率:-15.78
高:75.76
开:75.10
低:72.69
收:75.05
数据加载中...
2024/11/19

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/21

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/10

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/19

重要事件披露

Form 8-K - Current report
2024/07/19

重要事件披露

Form 8-K - Current report
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities